Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies

"FDA has no power to correct an alleged mistake it made six years ago," Ranbaxy said in the court filing dated Nov. 14 and seen by Reuters on Tuesday.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news